FITC Anti-Human CD20 Antibody[BCA/B20]

The FITC Anti-Human CD20 Antibody [BCA/B20] is a highly specific and reliable tool for the detection and analysis of CD20 expression in human samples. This antibody is conjugated with fluorescein isothiocyanate (FITC), a fluorochrome that emits a bright green fluorescence upon excitation with appropriate wavelengths.

CD20 is a transmembrane protein that is primarily expressed on the surface of B cells, making it an important marker for the identification and characterization of B lymphocytes. The FITC Anti-Human CD20 Antibody [BCA/B20] binds specifically to the extracellular domain of CD20, allowing for the visualization and quantification of CD20-positive cells by flow cytometry or fluorescence microscopy.

The FITC conjugation of this antibody provides several advantages. Firstly, FITC is a widely used fluorochrome with excellent photostability and brightness, ensuring accurate and reliable detection of CD20 expression. Additionally, FITC is compatible with a variety of instruments and can be easily combined with other fluorochromes for multiparametric analysis.

The FITC Anti-Human CD20 Antibody [BCA/B20] has been extensively validated for its specificity and sensitivity. It exhibits minimal cross-reactivity with other antigens, ensuring accurate identification of CD20-positive cells. Furthermore, this antibody demonstrates high sensitivity, allowing for the detection of low levels of CD20 expression.

This antibody is supplied as a liquid formulation in a convenient size of 100 tests per vial. It is ready-to-use and does not require any additional reagents or buffers for its application. The FITC Anti-Human CD20 Antibody [BCA/B20] is suitable for use in research and diagnostic laboratories, as well as in clinical settings.

In summary, the FITC Anti-Human CD20 Antibody [BCA/B20] is a highly specific and reliable tool for the detection and analysis of CD20 expression in human samples. Its FITC conjugation, specificity, and sensitivity make it an ideal choice for researchers and clinicians working in the field of B cell biology and immunology.